Decatur Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Decatur Capital Management's BMY Position: Q3 2021 in Review
Decatur Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 52,728 shares — an estimated $3.52M sold.
Decatur Capital Management first reported a position in BMY in Q2 2017 and held it in 17 quarters. The position peaked at $11.6M in Q3 2017. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Decatur Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
- Decatur Capital Management sold 52,728 Bristol-Myers Squibb shares in Q3 2021, an estimated $3.52M.
- Decatur Capital Management first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 17 quarters.
- Decatur Capital Management's Bristol-Myers Squibb position peaked at $11.6M in Q3 2017.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Decatur Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.